Sector
PharmaceuticalsOpen
₹730Prev. Close
₹723.1Turnover(Lac.)
₹227.32Day's High
₹757Day's Low
₹725.852 Week's High
₹83052 Week's Low
₹263.55Book Value
₹256.94Face Value
₹10Mkt Cap (₹ Cr.)
2,648.73P/E
0EPS
0Divi. Yield
028 Aug 2024
12:00 AM
BookCloser
15 Jul 2024
12:00 AM
Board Meeting
Agenda : Audited Result
9 May 2024
12:00 AM
Rights
29 Aug 2024
12:00 AM
AGM
Announcement Date: 29 Aug, 2024
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 36 | 36 | 36 | 35.93 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 901.42 | 1,467.13 | 1,491.05 | 1,556.86 |
Net Worth | 937.42 | 1,503.13 | 1,527.05 | 1,592.79 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 1,268.34 | 1,616.88 | 1,321.75 | 560.4 |
yoy growth (%) | -21.55 | 22.32 | 135.85 | |
Raw materials | -653.89 | -724.41 | -598.87 | -293.32 |
As % of sales | 51.55 | 44.8 | 45.3 | 52.34 |
Employee costs | -234.2 | -227.63 | -202.24 | -69.51 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | -88.17 | 220.96 | 112.49 | 1.95 |
Depreciation | -112.01 | -108.31 | -93.67 | -36.55 |
Tax paid | 33.1 | 0 | 0 | 0 |
Working capital | 200.65 | 302.71 | 157.99 | |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -21.55 | 22.32 | 135.85 | |
Op profit growth | -79.14 | 50.2 | 317.87 | |
EBIT growth | -104.22 | 60.44 | 601.98 | |
Net profit growth | -126.5 | 96.42 | 5,668.71 |
| Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|---|
Gross Sales | 1,288.92 | 1,443.81 | 1,268.34 | 1,616.88 | 1,321.75 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 1,288.92 | 1,443.81 | 1,268.34 | 1,616.88 | 1,321.75 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 5.37 | 22.55 | 20.02 | 28.77 | 27.52 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,917.15 | 165.25 | 4,59,916.52 | 237.82 | 0.7 | 4,409.74 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 5,547.05 | 88.65 | 1,47,255.42 | 430 | 0.54 | 2,063 | 507.93 |
Cipla Ltd CIPLA | 1,640.7 | 33.36 | 1,32,489.44 | 1,055.94 | 0.79 | 3,752.25 | 346.39 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,517.45 | 79.25 | 1,19,108.83 | 469 | 0.8 | 2,394 | 201.77 |
Dr Reddys Laboratories Ltd DRREDDY | 6,656.05 | 26.98 | 1,11,134.21 | 1,417.2 | 0.6 | 5,823.9 | 1,458.55 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Independent Directo
RAJAGOPALAN RAMAKRISHNAN
Independent Director
Kausalya Santhanam
Non Executive Director
Arun Kumar
Managing Director & CEO
Poorvank Purohit
Independent Director
Rajendra Kumar Srivastava
Non Executive Director
Rajiv Vijay Nabar
Non Executive Director
Kartheek Chintalapati Raju
Non Executive Director
Manish Gupta
Executive Director & COO
M Mohan
Company Sec. & Compli. Officer
S Murali Krishna
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Solara Active Pharma Sciences Ltd
Summary
Solara Active Pharma Sciences Limited was incorporated on February 23, 2017 to undertake business in manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading of and dealing in active pharmaceutical ingredients (APIs). The Company has 6 APIs manufacturing plants located in Ambernath, Mangalore, Mysuru, Puducherry, Vishakhapatnam, and Cuddalore with a capacity of over 2,580 kilo litres and two R&D Centres in Chennai and Bengaluru. The Company offer rich basket of niche high-value products for global markets. The Company has developed 80+ commercial APIs predominantly in anthelmintic, anti-malarias, anti-infective, neuromuscular insomnia and anti-psychotic hyperkalemia segments, among others. It also reinforce entry barriers to competition and build strong intrinsic value through market specific launches. Apart from this, the Solara Active has two research and development units - in Bengaluru and Chennai - equipped with state-of-the-art facilities and a pipeline of 25+ products, at different stages of development. These drugs primarily deal with anthelmintic, anti-malarias, beta blockers, muscle relaxants, novel oral anticoagulants, anti-infective and other niche segments.The Companys manufacturing facilities enjoy regulatory approvals from the United States Food and Drug Administration (USFDA); European Directorate for the Quality of Medicines (EDQM); Korea Food & Drug Administration (KFDA) - South Korea; Euro Zone - Good Ma
Read More
What is the Solara Active Pharma Sciences Ltd share price today?
The Solara Active Pharma Sciences Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹735.65 today.
What is the Market Cap of Solara Active Pharma Sciences Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Solara Active Pharma Sciences Ltd is ₹2648.73 Cr. as of 09 Oct ‘24
What is the PE and PB ratio of Solara Active Pharma Sciences Ltd?
The PE and PB ratios of Solara Active Pharma Sciences Ltd is 0 and 2.78 as of 09 Oct ‘24
What is the 52 Week High and Low of Solara Active Pharma Sciences Ltd?
The 52-week high/low is the highest and lowest price at which a Solara Active Pharma Sciences Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Solara Active Pharma Sciences Ltd is ₹263.55 and ₹830 as of 09 Oct ‘24
What is the CAGR of Solara Active Pharma Sciences Ltd?
Solara Active Pharma Sciences Ltd's CAGR for 5 Years at 16.42%, 3 Years at -18.56%, 1 Year at 131.64%, 6 Month at 78.02%, 3 Month at 19.22% and 1 Month at -7.78%.
What is the shareholding pattern of Solara Active Pharma Sciences Ltd?
The shareholding pattern of Solara Active Pharma Sciences Ltd is as follows:
Promoters - 37.27 %
Institutions - 16.83 %
Public - 45.90 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice
